These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37294412)

  • 1. Exploration of Digital Image Analysis for Ki67 Quantification in the Grading of Medullary Thyroid Carcinoma: A Pilot Study with 85 Cases.
    Behrman DB; Lubin DJ; Magliocca K; Shi Q; Viswanathan K
    Head Neck Pathol; 2023 Sep; 17(3):638-646. PubMed ID: 37294412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience.
    Lubin DJ; Behrman DB; Goyal S; Magliocca K; Shi Q; Chen AY; Viswanathan K
    Mod Pathol; 2023 Sep; 36(9):100235. PubMed ID: 37270155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation.
    Viswanathan K; Behrman DB; Lubin DJ
    Cancer Cytopathol; 2024 Apr; 132(4):224-232. PubMed ID: 38062948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading of Medullary Thyroid Carcinoma: an Interobserver Reproducibility Study.
    Williams JF; Zhao M; Najdawi F; Ahmadi S; Hornick JL; Wong KS; Barletta JA
    Endocr Pathol; 2022 Sep; 33(3):371-377. PubMed ID: 35553368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Validation of Three Available Grading Systems for Medullary Thyroid Carcinoma in a Single Institution Cohort.
    Vissio E; Maletta F; Fissore J; Osella Abate S; Retta F; Brizzi MP; Piovesan A; Rossetto Giaccherino R; Volante M; Papotti M
    Endocr Pathol; 2022 Sep; 33(3):359-370. PubMed ID: 35583706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.
    Xu B; Fuchs TL; Ahmadi S; Alghamdi M; Alzumaili B; Bani MA; Baudin E; Chou A; De Leo A; Fagin JA; Ganly I; Glover A; Hartl D; Kanaan C; Khneisser P; Najdawi F; Nigam A; Papachristos A; Repaci A; Spanheimer PM; Solaroli E; Untch BR; Barletta JA; Tallini G; Al Ghuzlan A; Gill AJ; Ghossein RA
    J Clin Oncol; 2022 Jan; 40(1):96-104. PubMed ID: 34731032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience.
    Rai V; Saha A; Mehta S; Shah RA; Trivedi P; Samanta ST; Rathod P; Manimaran P
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1571-1579. PubMed ID: 38010402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma.
    Censi S; Galuppini F; Clausi C; Battheu F; Manso J; Piva I; Corvaglia S; Pedron MC; Mondin A; Iacobone M; Torresan F; Merante Boschin I; Bertazza L; Barollo S; Pennelli G; Mian C
    Thyroid; 2024 Feb; 34(2):177-185. PubMed ID: 38047536
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
    Nigam A; Xu B; Spanheimer PM; Ganly I; Tuttle RM; Wong RJ; Shaha AR; Ghossein RA; Untch BR
    Thyroid; 2022 Oct; 32(10):1193-1200. PubMed ID: 35950622
    [No Abstract]   [Full Text] [Related]  

  • 10. Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion.
    Torricelli F; Santandrea G; Botti C; Ragazzi M; Vezzani S; Frasoldati A; Ghidini A; Giordano D; Zanetti E; Rossi T; Nicoli D; Ciarrocchi A; Piana S
    Mod Pathol; 2023 Sep; 36(9):100244. PubMed ID: 37307881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
    Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
    Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
    Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
    Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma.
    Jung CK; Agarwal S; Hang JF; Lim DJ; Bychkov A; Mete O
    Endocr Pathol; 2023 Mar; 34(1):1-22. PubMed ID: 36890425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms.
    Nadeem S; Hanna MG; Viswanathan K; Marino J; Ahadi M; Alzumaili B; Bani MA; Chiarucci F; Chou A; De Leo A; Fuchs TL; Lubin DJ; Luxford C; Magliocca K; Martinez G; Shi Q; Sidhu S; Al Ghuzlan A; Gill AJ; Tallini G; Ghossein R; Xu B
    Histopathology; 2023 Dec; 83(6):981-988. PubMed ID: 37706239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis.
    Fuchs TL; Nassour AJ; Glover A; Sywak MS; Sidhu SB; Delbridge LW; Clifton-Bligh RJ; Gild ML; Tsang V; Robinson BG; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
    Am J Surg Pathol; 2020 Oct; 44(10):1419-1428. PubMed ID: 32452872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
    Aksoy YA; Xu B; Viswanathan K; Ahadi MS; Al Ghuzlan A; Alzumaili B; Bani MA; Barletta JA; Chau N; Chou A; Clarkson A; Clifton-Bligh RJ; De Leo A; Dogan S; Ganly I; Ghossein R; Gild ML; Glover AR; Hadoux J; Lamartina L; Lubin DJ; Magliocca K; Najdawi F; Nigam A; Papachristos A; Repaci A; Robinson BG; Sheen A; Shi Q; Sidhu SB; Sioson L; Solaroli E; Sywak MS; Tallini G; Tsang V; Turchini J; Untch BR; Gill AJ; Fuchs TL
    Histopathology; 2024 May; 84(6):947-959. PubMed ID: 38253940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grading system for medullary thyroid carcinoma; an institutional experience.
    Podany P; Meiklejohn K; Garritano J; Holt EH; Barbieri A; Prasad M; Gilani SM
    Ann Diagn Pathol; 2023 Jun; 64():152112. PubMed ID: 36736129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Image Analysis of Ki67 Heterogeneity Improves the Diagnosis and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Zhang M; Tan C; Wang X; Ding X; Zhang B; Yang Z; Wang Y; Sheng W; Huang D
    Mod Pathol; 2023 Jan; 36(1):100017. PubMed ID: 36788066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
    Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
    Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with Prognosis.
    Saglietti C; La Rosa S; Sykiotis GP; Letovanec I; Bulliard JL; Piana S; Mermod M; Petrova T; Uccella S; Sessa F; Bongiovanni M
    Endocr Pathol; 2019 Jun; 30(2):138-145. PubMed ID: 31001799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.